Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Axitinib SR by Alcon for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Axitinib SR is under clinical development by Alcon and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration....